SCM
RCEL icon

Semanteon Capital Management’s Avita Medical RCEL Stock Holding History

Semanteon Capital Management’s Portfolio RCEL Stock Details RCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-11,110
Closed -$178K – 289
2024
Q1 		$178K Buy
+11,110
New +$180K 0.11% 204

Other funds holding RCEL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Semanteon Capital Management's RCEL Position: Q2 2024 in Review

Semanteon Capital Management sold out of Avita Medical (RCEL) in Q2 2024, closing a stake of 11,110 shares — an estimated $178K sold.

Semanteon Capital Management first reported a position in RCEL in Q1 2024 and held it in 1 quarter. The position peaked at $178K in Q1 2024. 68 funds tracked by Wall St. Rank hold RCEL as of Q2 2024.

  • Semanteon Capital Management reported no remaining Avita Medical position as of Q2 2024 after selling out during the quarter.
  • Semanteon Capital Management sold 11,110 Avita Medical shares in Q2 2024, an estimated $178K.
  • Semanteon Capital Management first reported a position in Avita Medical in Q1 2024 and held it in 1 quarter.
  • Semanteon Capital Management's Avita Medical position peaked at $178K in Q1 2024.
  • 68 funds tracked by Wall St. Rank held Avita Medical as of Q2 2024.

Based on Semanteon Capital Management's 13F filing for Q2 2024, filed 30 Jul 2024.